We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAN
476
DELISTED
The Aaron's Company Inc
AAN
| $3.03M | 0.02% |
253,919
-206,753
| -45% | -$2.21M |
|
477
S&T Bancorp
STBA
$1.88B
| $3.03M | 0.02% |
88,584
-969
| -1% | -$33.9K |
|
478
Lowe's Companies
LOW
$118B
| $3.01M | 0.02% |
15,123
-27,636
| -65% | -$5.52M |
|
479
Smith & Wesson
SWBI
$669M
| $2.96M | 0.02% |
340,984
-365,737
| -52% | -$3.85M |
|
480
Iovance Biotherapeutics
IOVA
$2.09B
| $2.95M | 0.02% |
461,460
+276,063
| +149% | +$2.16M |
|
|
MRSN
481
DELISTED
Mersana Therapeutics
MRSN
| $2.95M | 0.02% |
20,126
+3,979
| +25% | +$672K |
|
482
Howard Hughes
HHH
$3.87B
| $2.92M | 0.02% |
+40,107
| New | +$2.55M |
|
483
PJT Partners
PJT
$4.33B
| $2.9M | 0.02% |
39,361
-1,784
| -4% | -$134K |
|
|
QUOT
484
DELISTED
Quotient Technology Inc
QUOT
| $2.9M | 0.02% |
845,617
-479,505
| -36% | -$1.36M |
|
485
Hyster-Yale Materials Handling
HY
$600M
| $2.9M | 0.02% |
114,590
-15,696
| -12% | -$437K |
|
486
AutoNation
AN
$7.18B
| $2.9M | 0.02% |
26,981
-2,389
| -8% | -$264K |
|
487
MasterCraft Boat Holdings
MCFT
$597M
| $2.85M | 0.02% |
110,345
+14,757
| +15% | +$348K |
|
488
Ribbon Communications
RBBN
$373M
| $2.83M | 0.02% |
1,014,477
+429,592
| +73% | +$1.11M |
|
489
Axcelis
ACLS
$3.85B
| $2.83M | 0.02% |
35,642
-104,930
| -75% | -$7.39M |
|
490
Arcutis Biotherapeutics
ARQT
$3.5B
| $2.82M | 0.02% |
190,818
-41,395
| -18% | -$723K |
|
|
CMRX
491
DELISTED
Chimerix, Inc.
CMRX
| $2.82M | 0.02% |
1,518,224
+1,387,961
| +1,066% | +$2.72M |
|
492
Haverty Furniture Companies
HVT
$403M
| $2.82M | 0.02% |
94,357
-114,670
| -55% | -$3.35M |
|
|
RYZ
493
Ryerson Holding Corp
RYZ
$1.39B
| $2.78M | 0.02% |
92,031
+61,305
| +200% | +$1.82M |
|
|
PPL
494
PPL Corp
PPL
$26.8B
| $2.78M | 0.02% |
95,044
-16,735
| -15% | -$460K |
|
495
Trex
TREX
$4.56B
| $2.77M | 0.02% |
65,465
-28,309
| -30% | -$1.29M |
|
496
Amgen
AMGN
$209B
| $2.76M | 0.02% |
+10,516
| New | +$2.82M |
|
497
Nicolet Bankshares
NIC
$3.57B
| $2.73M | 0.02% |
34,185
-668
| -2% | -$52K |
|
498
Telos
TLS
$324M
| $2.66M | 0.02% |
522,806
+174,209
| +50% | +$1.15M |
|
|
GTLS
499
DELISTED
Chart Industries
GTLS
| $2.66M | 0.02% |
+23,049
| New | +$3.7M |
|
500
Allegro MicroSystems
ALGM
$7.72B
| $2.65M | 0.02% |
88,155
+40,076
| +83% | +$1.09M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.